Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 1202677019 | Drospirenone + ethinyl estradiol 3mg/0.03mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1207720018 | Drospirenone + ethinyl oestradiol 3mg/0.03mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1208531010 | Drospirenone + ethinyl estradiol 3mg/0.03mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1475919014 | Drospirenone+ethinyl oestradiol 3mg/0.03mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1476880014 | Drospirenone+ethinyl estradiol 3mg/0.03mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 3490460017 | Product containing drospirenone 3 mg and ethinyl estradiol 0.03 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3494275019 | Product containing drospirenone 3 mg and ethinyl estradiol 0.03 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3501666017 | Drospirenone 3 mg and ethinyl estradiol 0.03 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3569281013 | Product containing only drospirenone 3 mg and ethinyl estradiol 0.03 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3569282018 | Product containing only drospirenone 3 mg and ethinyl estradiol 0.03 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3699645010 | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 3699646011 | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3699647019 | Drospirenone 3 mg and ethinylestradiol 30 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 3699648012 | Drospirenone 3 mg and ethinyl estradiol 30 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 46812701000001115 | Drospirenone 3mg / Ethinylestradiol 30microgram tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module | 
| 60245801000001119 | Ethinylestradiol 30microgram / Drospirenone 3mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Estradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing drospirenone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Drospirenone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing drospirenone and ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Progesterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing estradiol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.03 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Drospirenone | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Drospirenone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 3 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Drospirenone | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 3 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has precise active ingredient | Drospirenone | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has precise active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 30 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has precise active ingredient | Drospirenone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Drospirenone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Ethinylestradiol + Drospirenone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has specific active ingredient | Drospirenone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has specific active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Yasmin tablets (Pilsco Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Yasmin tablets (Schering Health Care Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Yasmin tablets (CST Pharma Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Lucette 0.03mg/3mg tablets (DE Pharmaceuticals) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Drospirenone 3mg / Ethinylestradiol 30microgram tablets 63 tablet | Is pack of | False | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Lucette 0.03mg/3mg tablets (Pilsco Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Yasmin tablets (Doncaster Pharmaceuticals Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Yasmin tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Drospirenone 3mg / Ethinylestradiol 30microgram tablets 63 tablet | Has VMP | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Yasmin tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Lucette 0.03mg/3mg tablets (Gedeon Richter (UK) Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Dretine 0.03mg/3mg tablets (Teva UK Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Ethinylestradiol 30microgram / Drospirenone 3mg tablets (J M McGill Ltd) | Is a | False | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Ethinylestradiol 30microgram / Drospirenone 3mg tablets (Colorama Pharmaceuticals Ltd) | Is a | False | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Ethinylestradiol 30microgram / Drospirenone 3mg tablets (Niche Pharma Ltd) | Is a | False | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Yacella 0.03mg/3mg tablets (Morningside Healthcare Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Ethinylestradiol 30microgram / Drospirenone 3mg tablets (DE Pharmaceuticals) | Is a | False | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Yiznell 0.03mg/3mg tablets (Lupin (Europe) Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) | Is a | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet | Has VMP | True | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets